Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $54.17 (+35.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/26/2014 Leerink Swann New Coverage Market Perform
(N/A)
40.00
(N/A)
40.30 39.87 -1.07% Details
10/4/2013 JPMorgan New Coverage Neutral
(N/A)
37.00
(N/A)
35.83 39.87 11.28% Details
Like ISIS Ratings? Also take a look at SNY, SAN, GSK, BIIB

ISIS Ratings News